Automated Scale-up System for Reversed Phase Purification Released  

Mass spectrometry & spectroscopy

Automated Scale-up System for Reversed Phase Purification Released  

09 Oct, 2014

Published over 11 years ago. See the latest and most current information on Mass spectrometry & spectroscopy.

Shimadzu has released its automated scale-up system named ASAPrep for RPC in reversed phase purification. ASAPrep is an acronym for ‘Automated Scale-up from Analytical to Preparative conditions’. It is an algorithm (patent pending) for calculation of optimal initial organic mobile phase concentration in preparative scale using the retention time acquired by LC-PDA-MS measurement and judging of the difference between success and failure of purification. Its calculation uses pre-registered ASAPrep operational expression on newly developed Open Solution Purification software.

ASAPrep for reversed phase purification (RPC) enables construction of a user-independent purification workflow. Based on an algorithm, the preparative method is created automatically, and users will save time and increase throughput. ASAPrep for RPC runs on an LCMS-2020 single quadrupole system in analytical and preparative mode.

A cycle from synthesis of New Chemical Entities (NCE) and purification to High Throughput Screening (HTS) needs to be turned around smoothly to enhance throughput in medicinal chemistry. In the case of NCE synthesis and HTS, its automation is recently advanced but the speed of purification does not match NCE synthesis and HTS.

Medicinal chemistry departments of large pharmaceutical industries are capable of synthesising hundreds of new compounds per day, but they cannot provide high purity compounds in sufficient amounts for HTS. This is because the quality of purification depends highly on the skills of the chromatographers.

Based on the requirements of Takeda’s researchers, Shimadzu and Takeda have jointly developed ASAPrep for RPC which can automatically predict success and failure of purification and determine an optimal preparative condition. Takeda is the largest pharmaceutical company in Japan and operates subsidiaries on all continents.

Dr Teruhisa Ueda, Managing Executive Officer, Director of Analysis and Measuring Business in Shimadzu, stated: “We are proud to contribute with a set-up of new purification workflow in Takeda’s chemistry department. We believe ASAPrep for RPC is a breakthrough in technology, and not only enables high throughput and automated purification, but also expands popularisation of reversed phase purification which has been avoided by researchers due to the hurdle of method development.”

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
EU ETS benchmark update puts industrial emissions data under sharper scrutiny
Explore more Arrow
Pollution Solutions Online
Next-generation reverse osmosis membranes for more efficient and cost-effective seawater desalination
Explore more Arrow
Petro Online
From specification to certification: Ensuring jet fuel conformity with reliable flash point testing
Explore more Arrow
Chromatography Today
Non-invasive flowmeters for real-time monitoring
Explore more Arrow